Oppenheimer raised the firm’s price target on Onto Innovation (ONTO) to $180 from $130 and keeps an Outperform rating on the shares. The firm notes Onto amended its proposed acquisition of Semilab assets to streamline antitrust review, removing the EIR product and trimming the deal price by 10%. Oppenheimer views this as a smart, pragmatic adjustment that avoids regulatory delay while preserving the core rationale. Management also reaffirmed Q3 guidance.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ONTO:
- Onto Innovation price target raised to $120 from $110 at Stifel
- Onto Innovation Amends Acquisition Deal with Semilab
- Onto Innovation price target raised to $170 from $145 at B. Riley
- CoreWeave upgraded, Lululemon downgraded: Wall Street’s top analyst calls
- Onto Innovation upgraded to Buy from Hold at Jefferies